Security key
15673T100
Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC)
CUSIP: 15673T100
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 180,747,818
- Total 13F shares
- 40,117,934
- Share change
- +16,968,689
- Total reported value
- $102,301,880
- Put/Call ratio
- 4.3%
- Price per share
- $2.55
- Number of holders
- 59
- Value change
- +$40,961,743
- Number of buys
- 37
- Number of sells
- 26
Report period
Q2 2024
Institutions
59
Top holders
10
IPSC full security history
Newer quarter: Q3 2024
Previous quarter: Q1 2024
Century Therapeutics, Inc. SEC filings
Century Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 15673T100
Recent filing periods:
Top shareholders of IPSC - Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VR Adviser, LLC |
13F
|
Company |
1.9%
|
3,405,133
|
$14,233,456 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
1.9%
|
3,371,228
|
$14,091,732 | — | 31 Mar 2024 | |
| Casdin Capital, LLC |
13F
|
Company |
1.8%
|
3,206,380
|
$13,402,668 | — | 31 Mar 2024 | |
| Boxer Capital, LLC |
13F
|
Company |
0.97%
|
1,750,000
|
$7,315,000 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.83%
|
1,498,181
|
$6,262,397 | — | 31 Mar 2024 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.72%
|
1,307,407
|
$5,464,961 | — | 31 Mar 2024 | |
| Avidity Partners Management LP |
13F
|
Company |
0.68%
|
1,221,555
|
$5,106,100 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.63%
|
1,138,653
|
$4,759,570 | — | 31 Mar 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.5%
|
900,000
|
$3,762,000 | — | 31 Mar 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.44%
|
797,460
|
$3,333,383 | — | 31 Mar 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.34%
|
615,143
|
$2,571,298 | — | 31 Mar 2024 | |
| Octagon Capital Advisors LP |
13F
|
Company |
0.3%
|
540,000
|
$2,257,200 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.28%
|
510,591
|
$2,134,504 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.27%
|
485,218
|
$2,028,211 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.2%
|
357,401
|
$1,493,936 | — | 31 Mar 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.16%
|
293,941
|
$1,228,673 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.12%
|
214,380
|
$896,109 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.1%
|
184,615
|
$771,691 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.09%
|
156,000
|
$652,000 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.08%
|
152,051
|
$635,573 | — | 31 Mar 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.07%
|
117,600
|
$491,568 | — | 31 Mar 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.05%
|
93,085
|
$389,095 | — | 31 Mar 2024 | |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC |
13F
|
Company |
0.04%
|
78,215
|
$326,939 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.04%
|
70,912
|
$296,412 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.03%
|
60,039
|
$250,963 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.03%
|
54,292
|
$226,940 | — | 31 Mar 2024 | |
| CORNERCAP INVESTMENT COUNSEL INC |
13F
|
Company |
0.03%
|
51,520
|
$215,354 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
42,343
|
$176,993 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.02%
|
39,283
|
$164,203 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.02%
|
33,638
|
$140,595 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.02%
|
31,160
|
$130,249 | — | 31 Mar 2024 | |
| HARBOURVEST PARTNERS LLC |
13F
|
Company |
0.02%
|
29,018
|
$121,295 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
28,718
|
$120,041 | — | 31 Mar 2024 | |
| Parametrica Management Ltd |
13F
|
Company |
0.02%
|
27,840
|
$116,371 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
25,680
|
$107,342 | — | 31 Mar 2024 | |
| Jump Financial, LLC |
13F
|
Company |
0.01%
|
22,330
|
$93,339 | — | 31 Mar 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.01%
|
18,907
|
$79,031 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
16,463
|
$68,816 | — | 31 Mar 2024 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
13,743
|
$57,446 | — | 31 Mar 2024 | |
| OCCUDO QUANTITATIVE STRATEGIES LP |
13F
|
Company |
0.01%
|
13,562
|
$56,689 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.01%
|
12,210
|
$51,038 | — | 31 Mar 2024 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.01%
|
11,820
|
$49,408 | — | 31 Mar 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.01%
|
11,580
|
$48,404 | — | 31 Mar 2024 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
11,543
|
$48,250 | — | 31 Mar 2024 | |
| Mirae Asset Global Investments Co., Ltd. |
13F
|
Company |
0.01%
|
11,130
|
$38,510 | — | 31 Mar 2024 | |
| Abel Hall, LLC |
13F
|
Company |
0.01%
|
10,071
|
$42,097 | — | 31 Mar 2024 | |
| FOUNDERS FINANCIAL SECURITIES LLC |
13F
|
Company |
0.01%
|
10,000
|
$41,800 | — | 31 Mar 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
9,734
|
$40,688 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
8,263
|
$34,539 | — | 31 Mar 2024 | |
| Catalyst Funds Management Pty Ltd |
13F
|
Company |
0%
|
6,900
|
$28,842 | — | 31 Mar 2024 |
Institutional Holders of Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) as of Q2 2024
As of 30 Jun 2024,
Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) was held by
59 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
40,117,934 shares.
The largest 10 holders included
Bain Capital Life Sciences Investors, LLC, VR Adviser, LLC, Casdin Capital, LLC, Boxer Capital, LLC, FMR LLC, BlackRock Inc., VANGUARD GROUP INC, DAFNA Capital Management LLC, Octagon Capital Advisors LP, and ADAGE CAPITAL PARTNERS GP, L.L.C..
This page lists
59
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
66
Q2 2024 holders
59
Holder diff
-7
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.